Compare SPWH & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPWH | LUNG |
|---|---|---|
| Founded | 1986 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2M | 57.9M |
| IPO Year | 2014 | 2020 |
| Metric | SPWH | LUNG |
|---|---|---|
| Price | $1.63 | $1.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $2.94 | ★ $5.38 |
| AVG Volume (30 Days) | ★ 1.1M | 335.8K |
| Earning Date | 06-02-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.64 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,209,182,000.00 | $90,497,000.00 |
| Revenue This Year | $2.38 | $2.48 |
| Revenue Next Year | N/A | $18.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.96 | ★ 8.01 |
| 52 Week Low | $1.08 | $1.13 |
| 52 Week High | $4.33 | $5.46 |
| Indicator | SPWH | LUNG |
|---|---|---|
| Relative Strength Index (RSI) | 60.80 | 49.21 |
| Support Level | $1.35 | $1.27 |
| Resistance Level | $3.30 | $1.93 |
| Average True Range (ATR) | 0.13 | 0.10 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 90.39 | 49.32 |
Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer. It provides a one-stop shopping experience that equips customers with the right quality, brand name hunting, shooting, fishing, and camping gear to maximize enjoyment of the outdoors. The company offers products in the categories of Camping, Apparel, Fishing, Footwear, Hunting and shooting, and Optics, Electronics, Accessories, and Other products. It provides products such as Backpacks, Jackets, Camp essentials, Hiking boots, GPS devices, ATV accessories and Fishing rods, among others. The company also offers an e-commerce experience, extensive in-store events and educational programming.
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.